Antiinfective Medicine Sales in Japan are projected to experience a downward trend from 2024 to 2028. The value of total sales forecasts illustrate a decrease from 1.0 in 2024, 0.9 in both 2025 and 2026, 0.8 in 2027, and 0.7 by 2028. Compared year-on-year, the variations are stable from 2024 to 2026, dropping by 10% by 2027 and 12.5% by 2028.
The Compound Annual Growth Rate (CAGR) over the forecasted period shows an average annual decline, highlighting a sustained decrease in the sales of antiinfective medicine in Japan.
Future trends to watch for include increased competition from generic drugs, advancements in alternative medical treatments, and potential shifts in healthcare policies that could impact the antiinfective medicine market.
